SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

BACKGROUND: Individuals with secondary immunodeficiencies belong to the most vulnerable groups to succumb to COVID-19 and thus are prioritized for SARS-CoV-2 vaccination. However, knowledge about the persistence and anamnestic responses following SARS-CoV-2-mRNA vaccinations is limited in these pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Angelika, Garner-Spitzer, Erika, Schötta, Anna-Margarita, Orola, Maria, Wessely, Andrea, Zwazl, Ines, Ohradanova-Repic, Anna, Weseslindtner, Lukas, Tajti, Gabor, Gebetsberger, Laura, Kratzer, Bernhard, Tomosel, Elena, Kutschera, Maximilian, Tobudic, Selma, Pickl, Winfried F., Kundi, Michael, Stockinger, Hannes, Novacek, Gottfried, Reinisch, Walter, Zielinski, Christoph, Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133631/
https://www.ncbi.nlm.nih.gov/pubmed/35634285
http://dx.doi.org/10.3389/fimmu.2022.889138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133631/
https://www.ncbi.nlm.nih.gov/pubmed/35634285
http://dx.doi.org/10.3389/fimmu.2022.889138

Ejemplares similares